Chemed (CHE) vs Privia Health Group (PRVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Chemed (CHE) has outperformed Privia Health Group (PRVA) over the past year, gaining 15.0% versus a loss of 15.5%. Over five years, CHE leads with a +16.6% price change compared with -13.7% for PRVA. Chemed is the larger company by market cap ($6.55 billion vs $2.59 billion), about 2.5 times the size.
On valuation, Chemed trades at a lower forward P/E (18.2x vs 19.1x for Privia Health Group). Chemed pays a dividend yielding 0.48%, while Privia Health Group does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | PRVA |
|---|---|---|
| Share price | $501.45 | $20.30 |
| Market cap | $6.55B | $2.59B |
| 1-day change | -1.65% | +0.10% |
| YTD return | +17.20% | -14.38% |
| 1-year return | +14.99% | -15.45% |
| 5-year return | +16.58% | -13.65% |
| P/E ratio (TTM) | 25.22 | 96.67 |
| Forward P/E | 18.22 | 19.13 |
| EPS (TTM) | $19.88 | $0.21 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $2.53B | — |
| Revenue growth (YoY) | +4.06% | — |
| Net income (latest FY) | $265.24M | — |
| Gross margin | 32.54% | — |
| Operating margin | 13.37% | — |
| Net margin | 10.48% | — |
| 52-week high | $557.00 | $28.82 |
| 52-week low | $365.21 | $18.92 |
| Distance from 52-week high | -9.97% | -29.56% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +13.99% | +55.02% |
| Average volume | 160.12K | 1.23M |
| Shares outstanding | 13.07M | 127.73M |
| Employees | 15,811 | 1,226 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Chemed is about 2.5 times larger than Privia Health Group by market value ($6.55B vs $2.59B).
- CHE has outperformed PRVA by 30.4 percentage points over the past year.
- Privia Health Group trades at a higher earnings multiple (96.7x vs 25.2x trailing P/E).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About Privia Health Group
PRVA stock →Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
Health Care · Medical/Nursing Services · 1,226 employees
CHE vs PRVA FAQ
Which is bigger, Chemed or Privia Health Group?
Chemed (CHE) is larger, with a market capitalization of $6.55B compared with $2.59B for Privia Health Group (PRVA).
Which stock has performed better over the past year, CHE or PRVA?
CHE returned +14.99% over the past 12 months, compared with -15.45% for PRVA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CHE or PRVA?
CHE has the lower trailing P/E at 25.2, versus 96.7 for PRVA. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Chemed or Privia Health Group?
Chemed pays a dividend yielding 0.48%, while Privia Health Group does not currently pay a regular dividend.
Are Chemed and Privia Health Group in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.